Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001104659-21-154295

Chief Medical Officer acquired 5,200 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

KREHER NERISSA · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-12-29 Exercise or conversion : show line 1 in the form +5,200 $2.10 $10,920 5,200 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-12-29 Option exercise : show line 2 in the form Stock Option (Right to Buy) −5,200 $2.10 2030-12-01 5,200 142,722 D
Loading xslF345X03/tm2136524-1_4seq1.xml…